Rosemina Merchant
Vermögen: 2 Mio $ am 31.05.2026
Vermögen: 2 Mio $ am 31.05.2026
Rosemina Merchant was the founder of Intelligene Expressions, Inc., founded in 1992, serving as Chief Operating Officer & VP-Manufacturing from 1992 to 2002.
Ms. Merchant is the founder of Medicenna Therapeutics, Inc., founded in 2011, holding the title of Director since 2011.
Merchant is the founder of Medicenna Therapeutics Corp., founded in 2011, serving as Chief Development Officer since 2023.
Current jobs include Director at Aries Biologics, Inc., and Vice President-International Regulatory Affairs at Intelligenetics, Inc. since 2001.
Former job includes Vice President-Regulatory Affairs & Development at Sophiris Bio, Inc. from 2004 to 2013.
Education includes graduate degree from the University of Western Ontario and undergraduate degree from the University of Aston.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.12.2025 | 5’596’490 ( 8.14% ) | 2 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Gründer | 01.10.2011 |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Develops DNA and protein sequence analysis software | General Counsel | 01.01.2001 |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Gründer | 30.10.2011 |
Aries Biologics, Inc. | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
| SOPHIRIS BIO | General Counsel | 01.01.2013 |
Intelligene Expressions, Inc. | Gründer | 01.01.2002 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Sophiris Bio, Inc.
Sophiris Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of urological diseases | Health Technology |
Intelligenetics, Inc.
Intelligenetics, Inc. Information Technology ServicesTechnology Services Develops DNA and protein sequence analysis software | Technology Services |
University of Western Ontario
University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Aston
University of Aston Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aries Biologics, Inc. | |
Intelligene Expressions, Inc. | |
Medicenna Therapeutics, Inc.
Medicenna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for the treatment of central nervous system and urological cancers | Health Technology |
Medicenna Therapeutics Corp.
Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen